½ÃÀ庸°í¼­
»óǰÄÚµå
1715166

ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå ¿¹Ãø(-2031³â) : Áö¿ªº° ºÐ¼®(Á¦Ç°º°, ÀûÀÀÁõº°, Ä«Å×°í¸®º°, ½Ã½ºÅÛ À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº°)

North America Intermittent Catheters Market Forecast to 2031 - Regional Analysis - by Product, Indication, Category, System Type, and End User

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: The Insight Partners | ÆäÀÌÁö Á¤º¸: ¿µ¹® 101 Pages | ¹è¼Û¾È³» : Áï½Ã¹è¼Û

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀåÀº 2023³â¿¡ 10¾ï 3,579¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2031³â¿¡´Â 15¾ï 664¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2023³âºÎÅÍ 2031³â±îÁö CAGR 4.8%·Î ÃßÁ¤µË´Ï´Ù.

¿ä½Ç±Ý ±ÞÁõÀ¸·Î ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå Ȱ¼ºÈ­

¿ä½Ç±Ý(UI)Àº ¼¼°èÀÇ »ó´çÇÑ Àα¸¿¡ ¿µÇâÀ» ¹ÌÄ¡´Â °¡Àå ÀϹÝÀûÀÎ ¹®Á¦ÀÔ´Ï´Ù. ºñ¸¸ À¯º´·ü Áõ°¡, ³ë³â Àα¸ Áõ°¡, Àü¸³¼±¾Ï, ´ç´¢º´, ½ÅÀå Áúȯ, ´Ù¹ß¼º °æÈ­Áõ µîÀÇ ¸¸¼º ÁúȯÀÇ ÀÌȯÀ² Áõ°¡´Â UIÀÇ ÁÖ¿ä À§Çè ÀÎÀÚ Áß ÇϳªÀÔ´Ï´Ù.

UI°¡ ÀÇ·á½Ã½ºÅÛ¿¡ ÁÖ´Â °æÁ¦Àû ºÎ´ãÀº ¼¼°è °í·ÉÀÚ Àα¸°¡ ±ÞÁõÇÔ¿¡ µû¶ó Ä¿Áö°í ÀÖ½À´Ï´Ù. Mayo Clinic Health SystemÀÌ 2023³â¿¡ ¹ßÇ¥ÇÑ ±â»ç¿¡ ÀÇÇϸé, ¼Òº¯ ´©¼³Àº °í·ÉÀÚ Àα¸ÀÇ 50% °¡±îÀ̰¡ ÀÌȯÇÏ´Â ÀϹÝÀûÀÎ Áõ»óÀÔ´Ï´Ù. ÀÌ Áõ»óÀÇ À¯º´·üÀº ¿¬·É°ú ÇÔ²² Áõ°¡Çϸç, ¾î´À ¿¬·ÉÃþÀÇ ³²¼ºº¸´Ùµµ ¿©¼º¿¡°Ô ¸¹¾Æ 65¼¼ ÀÌ»óÀÇ ¿©¼ºÀÇ ÃÖ´ë 75%°¡ ¼Òº¯ ´©¼³¿¡ ½Ã´Þ¸®°í ÀÖ½À´Ï´Ù. ¹æ±¤ÀÌ ºñ¿öÁø ÈÄ, Ä«Å×Å͸¦ ºüÁ® ³ª°¡¸é ¾Æ¹«·± ÁöÀåµµ °ÆÁ¤ÇÏÁö ¾Ê°í ÀÏ»ó »ýȰÀ» °è¼ÓÇÒ ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼­ UI À¯º´·üÀÇ »ó½ÂÀÌ °£Çæ Ä«Å×ÅÍ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇϰí ÀÖ½À´Ï´Ù.

ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå °³¿ä

Àα¸¹®Á¦¿¬±¸¼Ò¿¡ µû¸£¸é 65¼¼ ÀÌ»óÀÇ °í·ÉÀÚ ¼ö´Â 2023³â¿¡´Â 5,800¸¸¸íÀ¸·Î, 2050³â¿¡´Â 8,200¸¸¸íÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ÃßÁ¤µÇ°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ Áúº´ °ü¸® ¿¹¹æ ¼¾ÅÍ¿¡ µû¸£¸é, ¿ä½Ç±ÝÀº ´ç´¢º´À̳ª ³úÁ¹Áß µîÀÇ ¸¸¼º Áúȯ, ÀÎÁö Àå¾Ö, ÀÌȯ Àå¾Ö µî ´Ù¾çÇÑ ¿äÀÎÀ¸·ÎºÎÅÍ, 65¼¼ ÀÌ»óÀÇ °í·ÉÀÚÀÇ ÁÖ¿ä Áõ»ó°ú ¶ÇÇÑ ¹Ì±¹ ô¼ö ¼Õ»ó Åë°è ¼¾ÅÍ¿¡ µû¸£¸é ¸Å³â 17,500 ¸íÀÌ SCI¸¦ ¾Î°í ÀÖÀ¸¸ç ƯÈ÷ ³ë³â Àα¸°¡ ¸¹´Ù°í ÃßÁ¤µË´Ï´Ù. ÅëÁ¦¸¦ À§ÇØ ¿äµµ Ä«Å×ÅÍÀÇ µµ¿òÀÌ ÇÊ¿äÇÏ¸ç ¿äµµ Ä«Å×ÅͰ¡ ÁÖ·Î »ç¿ëµË´Ï´Ù.

ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå ¼öÀͰú 2031³â±îÁö ¿¹Ãø(±Ý¾× ±âÁØ)

ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå ¼¼ºÐÈ­

ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀåÀº Á¦Ç° À¯Çü, ÀûÀÀÁõ, Ä«Å×°í¸®, ½Ã½ºÅÛ À¯Çü, ÃÖÁ¾ »ç¿ëÀÚ, ±¹°¡·Î ºÐ·ùµË´Ï´Ù.

Á¦Ç°º°·Î ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀåÀº ÄÚÆÃÇü °£Çæ Ä«Å×ÅÍ¿Í ºñÄÚÆÃÇü °£Çæ Ä«Å×ÅÍ·Î ±¸ºÐµË´Ï´Ù.

ÀûÀÀÁõº°·Î ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀåÀº ¿ä½Ç±Ý, ÀÏ¹Ý ¼ö¼ú, ô¼ö ¼Õ»ó, ÆÄŲ½¼º´(pd), ´Ù¹ß¼º °æÈ­Áõ µîÀ¸·Î ±¸ºÐµË´Ï´Ù.

¹üÁÖº°·Î º¸¸é ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀåÀº ¿©¼º¿ë Ä«Å×ÅÍ, ³²¼º¿ë Ä«Å×ÅÍ, ¾Æµ¿¿ë Ä«Å×ÅÍ·Î ºÐ·ùµË´Ï´Ù.

½Ã½ºÅÛ À¯Çüº°·Î ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀåÀº Æó¼âÇü °£Çæ Ä«Å×ÅÍ ½Ã½ºÅÛ°ú °³¹æÇü °£Çæ Ä«Å×ÅÍ ½Ã½ºÅÛÀ¸·Î 2ºÐÈ­µË´Ï´Ù.

ÃÖÁ¾ »ç¿ëÀÚº°·Î ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀåÀº º´¿ø, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC), ÀçÅÃÄ¡·á µîÀ¸·Î ±¸ºÐµË´Ï´Ù.

±¹°¡º°·Î ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀåÀº ¹Ì±¹, ij³ª´Ù, ¸ß½ÃÄÚ·Î ±¸ºÐµË´Ï´Ù.

Advin Health Care Pvt Ltd, B Braun SE, Boston Scientific Corp, Cardinal Health Inc, Coloplast Corp, Convatec Group Plc, Hollister Inc, Medical Technologies of Georgia, Inc, Teleflex Inc, Wellspect HealthCare µîÀÌ ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå¿¡¼­ »ç¾÷À» Àü°³ÇÏ´Â ÁÖ¿ä ±â¾÷ÀÔ´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼­·Ð

Á¦2Àå ÁÖ¿ä ¿ä¾à

  • ÁÖ¿ä ÀλçÀÌÆ®
  • ½ÃÀåÀÇ ¸Å·Â

Á¦3Àå ºÐ¼® ¹æ¹ý

  • 2Â÷ Á¶»ç
  • 1Â÷ Á¶»ç
    • °¡¼³ÀÇ Ã¥Á¤
    • °Å½Ã°æÁ¦ ¿äÀκм®
    • ±âÃÊ ¼öÄ¡ÀÇ °³¹ß
    • µ¥ÀÌÅÍÀÇ »ï°¢Ãø·®
    • ±¹°¡ ·¹º§ µ¥ÀÌÅÍ

Á¦4Àå ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå : ÁÖ¿ä ½ÃÀå ¿ªÇÐ

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¿ä½Ç±ÝÀÇ ±ÞÁõ
    • ÀÏȸ¿ë Ä«Å×ÅÍ Ã¤¿ë
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • Ä«Å×ÅÍ Ä¡·á¿¡ µû¸¥ ÇÕº´Áõ
  • ½ÃÀå ±âȸ
    • ÀÚ±â Ä«Å×ÅÍ Ä¡·áÀÇ Àαâ¿Í ¿äµµ Ä«Å×ÅÍ °³¹ß¿¡ ´ëÇÑ ÅõÀÚ Áõ¾×
  • ÇâÈÄÀÇ µ¿Çâ
    • ¸¶ÀÌÅ©·ÎȦ Á¸ Ä«Å×ÅÍ
  • ¼ºÀå ÃËÁø¿äÀΰú ¾ïÁ¦¿äÀÎÀÇ ¿µÇâ

Á¦5Àå °£Çæ Ä«Å×ÅÍ ½ÃÀå : ºÏ¹Ì ½ÃÀå ºÐ¼®

  • ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå ¼öÀÍ(2021-2031³â)
    • °³¿ä

Á¦6Àå ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå ºÐ¼® : Á¦Ç°º°

  • °³¿ä
  • ÄÚÆÃÇü °£Çæ Ä«Å×ÅÍ
  • ºñÄÚÆÃÇü °£Çæ Ä«Å×ÅÍ

Á¦7Àå ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå ºÐ¼® : ÀûÀÀÁõº°

  • °³¿ä
  • ¿ä½Ç±Ý
  • ÀÏ¹Ý ¿Ü°ú
  • ô¼ö ¼Õ»ó
  • ÆÄŲ½¼º´(PD)
  • ´Ù¹ß¼º °æÈ­Áõ
  • ±âŸ

Á¦8Àå ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå ºÐ¼® : Ä«Å×°í¸®º°

  • °³¿ä
  • ¿©¼º¿ë Ä«Å×ÅÍ
  • ³²¼º¿ë Ä«Å×ÅÍ
  • ¾Æµ¿¿ë Ä«Å×ÅÍ

Á¦9Àå ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå ºÐ¼® : ½Ã½ºÅÛ À¯Çüº°

  • °³¿ä
  • Æó¼âÇü °£Çæ Ä«Å×ÅÍ ½Ã½ºÅÛ
  • °³¹æÇü °£Çæ Ä«Å×ÅÍ ½Ã½ºÅÛ

Á¦10Àå ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå ºÐ¼® : ÃÖÁ¾ »ç¿ëÀÚº°

  • °³¿ä
  • º´¿ø
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ÀçÅÃÄ¡·á
  • ±âŸ

Á¦11Àå ºÏ¹ÌÀÇ °£Çæ Ä«Å×ÅÍ ½ÃÀå : ±¹°¡º° ºÐ¼®

  • °³¿ä
  • ¹Ì±¹
  • ij³ª´Ù
  • ¸ß½ÃÄÚ

Á¦12Àå °£Çæ Ä«Å×ÅÍ ½ÃÀå : ¾÷°è Á¤¼¼

  • °³¿ä
  • °£Çæ Ä«Å×ÅÍ ½ÃÀå¿¡¼­ÀÇ ¼ºÀå Àü·«

Á¦13Àå ±â¾÷ ÇÁ·ÎÆÄÀÏ

  • Coloplast Corp
  • Boston Scientific Corp
  • Hollister Inc
  • Teleflex Inc
  • Convatec Group Plc
  • B Braun SE
  • Cardinal Health Inc
  • Advin Health Care Pvt Ltd
  • Medical Technologies of Georgia, Inc.
  • Wellspect HealthCare

Á¦14Àå ºÎ·Ï

JHS 25.05.15

The North America intermittent catheters market was valued at US$ 1,035.79 million in 2023 and is expected to reach US$ 1,506.64 million by 2031; it is estimated to register a CAGR of 4.8% from 2023 to 2031.

Surging Prevalence of Urinary Incontinence Fuels North America Intermittent Catheters Market

Urinary incontinence (UI) is the most common problem affecting a substantial global population. It results in occasional or minor leaking or uncontrolled chronic urination, in worse cases. The growing prevalence of obesity; the increasing geriatric population; and the rising incidence of chronic diseases such as prostate cancer, diabetes, kidney diseases, and multiple sclerosis are among the prime risk factors for UI. Medical conditions such as spinal cord injuries, cerebral palsy, prostate enlargement, multiple sclerosis, and cancer, among others, may lead to UI in the geriatric population.

The economic burden of UI on healthcare systems grows with the surging elderly population across the world. According to the World Health Organization (WHO), the total population aged 60 and above was 1 billion in 2020, and it is expected to reach 1.4 billion by 2031. According to an article published by Mayo Clinic Health System in 2023, the uncontrolled leakage of urine is a common symptom that affects almost 50% of the elderly population. The prevalence of this condition increases with age, and it affects more women than men of any age; up to 75% of women over 65 suffer from urine leakage. Intermittent urinary catheters are inserted into the bladder of individuals through the urethra several times a day to carry urine out of their body; it is kept in the bladder for just long enough to drain it before removing it. By catheterizing themselves, people can gain better control over their bladder. Once the catheter is removed after the bladder is emptied, people can continue their daily activities without any hindrances and awkwardness. Thus, the rising prevalence of UI is driving the growth of the intermittent catheters market.

North America Intermittent Catheters Market Overview

According to the Population Reference Bureau, the number of people aged 65 and above was 58 million in 2023 and it is estimated to increase to 82 million by 2050. This aging population is more susceptible to spinal cord injury (SCI), urinary incontinence, and benign prostate hyperplasia. For instance, according to the Centers for Disease Control and Prevention, urinary incontinence is a major symptom among people aged 65 or above due to various factors, including chronic conditions such as diabetes and stroke, cognitive impairment, and morbidity impairment. Moreover, according to the National Spinal Cord Injury Statistical Center, it was estimated that each year, 17,500 people were suffering from SCI in the US, especially among the geriatric population. Patients affected by SCI majorly need the help of urinary catheterization to control neurogenic bladder dysfunction, where urinary catheters are mainly used. Thus, the growing use of urinary catheters is expected to fuel the growth of the urinary catheters market in the country.

North America Intermittent Catheters Market Revenue and Forecast to 2031 (US$ Million)

North America Intermittent Catheters Market Segmentation

The North America intermittent catheters market is categorized into product, indication, category, system type, end user, and country.

By product, the North America intermittent catheters market is segmented into coated intermittent catheters and uncoated intermittent catheters. The coated intermittent catheters segment held a larger share of the North America intermittent catheters market share in 2023.

In terms of indication, the North America intermittent catheters market is segmented into urinary incontinence, general surgeries, spinal cord injuries, Parkinson's Disease (pd), multiple sclerosis, and others. The urinary incontinence segment held the largest share of the North America intermittent catheters market share in 2023.

Based on category, the North America intermittent catheters market is female length catheters, male length catheters, and kid length catheters. The female length catheters segment held the largest share of the North America intermittent catheters market share in 2023.

By system type, the North America intermittent catheters market is bifurcated into closed intermittent catheters systems and open intermittent catheters systems. The closed intermittent catheters systems segment held a larger share of the North America intermittent catheters market share in 2023.

In terms of end user, the North America intermittent catheters market is segmented into hospitals, ambulatory surgical centers, home care settings, and others. The hospitals segment held the largest share of the North America intermittent catheters market share in 2023.

Based on country, the North America intermittent catheters market is segmented into the US, Canada, and Mexico. The US segment held the largest share of North America intermittent catheters market in 2023.

Advin Health Care Pvt Ltd; B Braun SE; Boston Scientific Corp; Cardinal Health Inc; Coloplast Corp; Convatec Group Plc; Hollister Inc; Medical Technologies of Georgia, Inc.; Teleflex Inc; and Wellspect HealthCare are some of the leading companies operating in the North America intermittent catheters market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macro-economic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country level data:

4. North America Intermittent Catheters Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Surging Prevalence of Urinary Incontinence
    • 4.1.2 Adoption of Single-Use Catheters
  • 4.2 Market Restraints
    • 4.2.1 Complications Associated with Catheterization
  • 4.3 Market Opportunities
    • 4.3.1 Growing Preference for Self-Catheterization and Increasing Investments in Urinary Catheter Developments
  • 4.4 Future Trends
    • 4.4.1 Micro-Hole Zone Catheters
  • 4.5 Impact of Drivers and Restraints:

5. Intermittent Catheters Market - North America Analysis

  • 5.1 North America Intermittent Catheters Market Revenue (US$ Million), 2021-2031
    • 5.1.1 Overview

6. North America Intermittent Catheters Market Analysis - by Product

  • 6.1 Overview
  • 6.2 Coated Intermittent Catheters
    • 6.2.1 Overview
    • 6.2.2 Coated Intermittent Catheters: North America Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
  • 6.3 Uncoated Intermittent Catheters
    • 6.3.1 Overview
    • 6.3.2 Uncoated Intermittent Catheters: North America Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)

7. North America Intermittent Catheters Market Analysis - by Indication

  • 7.1 Overview
  • 7.2 Urinary Incontinence
    • 7.2.1 Overview
    • 7.2.2 Urinary Incontinence: North America Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.3 General Surgery
    • 7.3.1 Overview
    • 7.3.2 General Surgery: North America Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.4 Spinal Cord Injuries
    • 7.4.1 Overview
    • 7.4.2 Spinal Cord Injuries: North America Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.5 Parkinson Disease (PD)
    • 7.5.1 Overview
    • 7.5.2 Parkinson Disease (PD): North America Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.6 Multiple Sclerosis
    • 7.6.1 Overview
    • 7.6.2 Multiple Sclerosis: North America Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
  • 7.7 Others
    • 7.7.1 Overview
    • 7.7.2 Others: North America Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)

8. North America Intermittent Catheters Market Analysis - by Category

  • 8.1 Overview
  • 8.2 Female Length Catheters
    • 8.2.1 Overview
    • 8.2.2 Female Length Catheters: North America Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.3 Male Length Catheters
    • 8.3.1 Overview
    • 8.3.2 Male Length Catheters: North America Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
  • 8.4 Kid Length Catheters
    • 8.4.1 Overview
    • 8.4.2 Kid Length Catheters: North America Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)

9. North America Intermittent Catheters Market Analysis - by System Type

  • 9.1 Overview
  • 9.2 Closed Intermittent Catheters Systems
    • 9.2.1 Overview
    • 9.2.2 Closed Intermittent Catheters Systems: North America Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
  • 9.3 Open Intermittent Catheters Systems
    • 9.3.1 Overview
    • 9.3.2 Open Intermittent Catheters Systems: North America Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)

10. North America Intermittent Catheters Market Analysis - by End User

  • 10.1 Overview
  • 10.2 Hospitals
    • 10.2.1 Overview
    • 10.2.2 Hospitals: North America Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.3 Ambulatory Surgical Centers
    • 10.3.1 Overview
    • 10.3.2 Ambulatory Surgical Centers: North America Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.4 Home Care Settings
    • 10.4.1 Overview
    • 10.4.2 Home Care Settings: North America Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
  • 10.5 Others
    • 10.5.1 Overview
    • 10.5.2 Others: North America Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)

11. North America Intermittent Catheters Market - Country Analysis

  • 11.1 North America Intermittent Catheters Market Overview
    • 11.1.1 North America Intermittent Catheters Market - Revenue and Forecast Analysis - by Country
      • 11.1.1.1 US: Intermittent Catheters Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.1.1 Overview
      • 11.1.1.2 United States: Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.1.1.2.1 United States: Intermittent Catheters Market Breakdown, by Product
        • 11.1.1.2.2 United States: Intermittent Catheters Market Breakdown, by Indication
        • 11.1.1.2.3 United States: Intermittent Catheters Market Breakdown, by Category
        • 11.1.1.2.4 United States: Intermittent Catheters Market Breakdown, by System Type
        • 11.1.1.2.5 United States: Intermittent Catheters Market Breakdown, by End User
      • 11.1.1.3 Canada: Intermittent Catheters Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.3.1 Overview
      • 11.1.1.4 Canada: Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.1.1.4.1 Canada: Intermittent Catheters Market Breakdown, by Product
        • 11.1.1.4.2 Canada: Intermittent Catheters Market Breakdown, by Indication
        • 11.1.1.4.3 Canada: Intermittent Catheters Market Breakdown, by Category
        • 11.1.1.4.4 Canada: Intermittent Catheters Market Breakdown, by System Type
        • 11.1.1.4.5 Canada: Intermittent Catheters Market Breakdown, by End User
      • 11.1.1.5 Mexico: Intermittent Catheters Market - Revenue and Forecast to 2030 (US$ Million)
        • 11.1.1.5.1 Overview
      • 11.1.1.6 Mexico: Intermittent Catheters Market - Revenue and Forecast to 2031 (US$ Million)
        • 11.1.1.6.1 Mexico: Intermittent Catheters Market Breakdown, by Product
        • 11.1.1.6.2 Mexico: Intermittent Catheters Market Breakdown, by Indication
        • 11.1.1.6.3 Mexico: Intermittent Catheters Market Breakdown, by Category
        • 11.1.1.6.4 Mexico: Intermittent Catheters Market Breakdown, by System Type
        • 11.1.1.6.5 Mexico: Intermittent Catheters Market Breakdown, by End User

12. Intermittent Catheters Market - Industry Landscape

  • 12.1 Overview
  • 12.2 Growth Strategies in Intermittent Catheters Market

13. Company Profiles

  • 13.1 Coloplast Corp
    • 13.1.1 Key Facts
    • 13.1.2 Business Description
    • 13.1.3 Products and Services
    • 13.1.4 Financial Overview
    • 13.1.5 SWOT Analysis
    • 13.1.6 Key Developments
  • 13.2 Boston Scientific Corp
    • 13.2.1 Key Facts
    • 13.2.2 Business Description
    • 13.2.3 Products and Services
    • 13.2.4 Financial Overview
    • 13.2.5 SWOT Analysis
    • 13.2.6 Key Developments
  • 13.3 Hollister Inc
    • 13.3.1 Key Facts
    • 13.3.2 Business Description
    • 13.3.3 Products and Services
    • 13.3.4 Financial Overview
    • 13.3.5 SWOT Analysis
    • 13.3.6 Key Developments
  • 13.4 Teleflex Inc
    • 13.4.1 Key Facts
    • 13.4.2 Business Description
    • 13.4.3 Products and Services
    • 13.4.4 Financial Overview
    • 13.4.5 SWOT Analysis
    • 13.4.6 Key Developments
  • 13.5 Convatec Group Plc
    • 13.5.1 Key Facts
    • 13.5.2 Business Description
    • 13.5.3 Products and Services
    • 13.5.4 Financial Overview
    • 13.5.5 SWOT Analysis
    • 13.5.6 Key Developments
  • 13.6 B Braun SE
    • 13.6.1 Key Facts
    • 13.6.2 Business Description
    • 13.6.3 Products and Services
    • 13.6.4 Financial Overview
    • 13.6.5 SWOT Analysis
    • 13.6.6 Key Developments
  • 13.7 Cardinal Health Inc
    • 13.7.1 Key Facts
    • 13.7.2 Business Description
    • 13.7.3 Products and Services
    • 13.7.4 Financial Overview
    • 13.7.5 SWOT Analysis
    • 13.7.6 Key Developments
  • 13.8 Advin Health Care Pvt Ltd
    • 13.8.1 Key Facts
    • 13.8.2 Business Description
    • 13.8.3 Products and Services
    • 13.8.4 Financial Overview
    • 13.8.5 SWOT Analysis
    • 13.8.6 Key Developments
  • 13.9 Medical Technologies of Georgia, Inc.
    • 13.9.1 Key Facts
    • 13.9.2 Business Description
    • 13.9.3 Products and Services
    • 13.9.4 Financial Overview
    • 13.9.5 SWOT Analysis
    • 13.9.6 Key Developments
  • 13.10 Wellspect HealthCare
    • 13.10.1 Key Facts
    • 13.10.2 Business Description
    • 13.10.3 Products and Services
    • 13.10.4 Financial Overview
    • 13.10.5 SWOT Analysis
    • 13.10.6 Key Developments

14. Appendix

  • 14.1 About The Insight Partners
  • 14.2 Glossary of Terms
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦